Am I immune to semaglutide
First, activation of AMPK may initiate cell cycle arrest in the G1 phase through inducing phosphorylation of the tumor suppressor p53 39,40
L., Vohra, S., and Goldman, R
Gastrointestinal Adverse Events GI AEs are the most frequently reported side effects of GLP-1 RAs and, although typically mild, moderate, and transient, they remain the primary reason for treatment discontinuation among individuals with obesity receiving semaglutide [13, 27, 38, 40,41,42,43,44,45,46, 52]
Recording weights in a journal or smartphone application allows you to visualize progress over time and identify patterns